Artificial metalloenzymes (ArMs), which combine an abiotic metal cofactor with a protein scaffold, catalyze various synthetically useful transformations. To complement the natural enzymes' repertoire, effective optimization protocols to improve ArM's performance are required. Here we report on our efforts to optimize the activity of an artificial transfer hydrogenase (ATHase) using E. coli whole cells. For this purpose, we rely on a self-immolative quinolinium substrate which, upon reduction, releases fluorescent umbelliferone, thus allowing efficient screening. Introduction of a loop in the immediate proximity of the Ircofactor afforded an ArM with up to fivefold increase in transfer hydrogenation activity compared to the wild-type ATHase using purified mutants.
The biotin–streptavidin technology
has been extensively
exploited to engineer artificial metalloenzymes (ArMs) that catalyze
a dozen different reactions. Despite its versatility, the homotetrameric
nature of streptavidin (Sav) and the noncooperative binding of biotinylated
cofactors impose two limitations on the genetic optimization of ArMs:
(i) point mutations are reflected in all four subunits of Sav, and
(ii) the noncooperative binding of biotinylated cofactors to Sav may
lead to an erosion in the catalytic performance, depending on the
cofactor:biotin-binding site ratio. To address these challenges, we
report on our efforts to engineer a (monovalent) single-chain dimeric
streptavidin (scdSav) as scaffold for Sav-based ArMs. The versatility
of scdSav as host protein is highlighted for the asymmetric transfer
hydrogenation of prochiral imines using [Cp*Ir(biot-p-L)Cl] as cofactor. By capitalizing on a more precise genetic fine-tuning
of the biotin-binding vestibule, unrivaled levels of activity and
selectivity were achieved for the reduction of challenging prochiral
imines. Comparison of the saturation kinetic data and X-ray structures
of [Cp*Ir(biot-p-L)Cl]·scdSav with a structurally
related [Cp*Ir(biot-p-L)Cl]·monovalent scdSav
highlights the advantages of the presence of a single biotinylated
cofactor precisely localized within the biotin-binding vestibule of
the monovalent scdSav. The practicality of scdSav-based ArMs was illustrated
for the reduction of the salsolidine precursor (500 mM) to afford
(R)-salsolidine in 90% ee and >17 000 TONs.
Monovalent scdSav thus provides a versatile scaffold to evolve more
efficient ArMs for in vivo catalysis and large-scale applications.
An artificial metathesase results from incorporation of an Hoveyda-Grubbs catalyst bearing an arylsulfonamide anchor within human carbonic anhydrase II. The optimization of the catalytic performance is achieved upon combining both chemical and genetic means. Up to 28 TONs were obtained within four hours under aerobic physiological conditions.
Co Cr Pt – Si O 2 perpendicular recording media containing dual-Ru intermediate layers have been studied. The bottom Ru layer deposited under a higher mobility condition, i.e., low Ar gas pressure and bias on substrate, helps to achieve a good crystalline texture, and the top Ru layer under a lower mobility condition, i.e., high Ar gas pressure, promotes the formation of a columnar microstructure. Three kinds of grain boundaries have been observed. The nucleation field and the coercivity as a function of the thickness and dc bias of the bottom Ru layer have been investigated. Medium noise reduction has been observed for dual-Ru intermediate layer media (dual-Ru media) in comparison with that of single intermediate layer media (single-Ru media). This is mainly attributed to the optimization of the physical grain segregation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.